Similar Articles
Efficacy of anakinra treatment in pediatric rheumatic diseases: Our single-center experience
Ferhat Demir, Eda Gürler, Betül Sözeri
DOI: 10.46497/ArchRheumatol.2022.8998
Issue: Volume 37 - Issue 3 - September 2022
1249
1033
The reliability of Juvenile Arthritis Magnetic Resonance Imaging Scoring system in the evaluation of the shoulder joint in juvenile idiopathic arthritis
Murugan Sudhakar, Shivani Deswal, Namrita Sachdev, Somdipa Pal, Tribhuvan Pal Yadav
DOI: 10.46497/ArchRheumatol.2022.9304
Issue: Volume 37 - Issue 4 - December 2022
821
838
Association of tumor necrosis factor-alpha promoter region gene polymorphism at positions -308G/A, -857C/T, and -863C/A with etanercept response in Iraqi rheumatoid arthritis patients
Samer Mohammed, Munaf Zalzala, Faiq Gorial
DOI: 10.46497/ArchRheumatol.2022.9272
Issue: Volume 37 - Issue 4 - December 2022
1090
894
The impact of COVID-19 on clinical course and treatment among patients with juvenile systemic sclerosis
Amra Adrovic, Mehmet Yıldız, Fatih Haşlak, Sezgin Şahin, Oya Köker, Aybüke Günalp, Kenan Barut, Özgür Kasapçopur
DOI: 10.46497/ArchRheumatol.2023.9636
Issue: Volume 38 - Issue 2 - June 2023
620
674
Pericardial effusion in children admitted with juvenile idiopathic arthritis: A multicenter retrospective cohort study from the pediatric health information system
Daniel Fiedorek, Xinyu Tang, Sukesh Sukumaran, R. Thomas Collins, Elijah Bolin
DOI: 10.46497/ArchRheumatol.2023.9690
Issue: Volume 38 - Issue 3 - September 2023
490
563
Risk of flare in juvenile idiopathic arthritis: Is it related to the methotrexate treatment strategy or patient characteristics?
Rana İşgüder, Zehra Kızıldağ, Rüya Torun, Tuncay Aydın, Balahan Makay, Erbil Ünsal
DOI: 10.46497/ArchRheumatol.2023.10035
Issue: Volume 38 - Issue 4 - December 2023
455
498